Neuro Vigor Therapeutics is a development stage company focused on reducing RAS, a significant contributor to the initiation, progression and symptoms of multiple diseases, trauma and pain.
Extensive research demonstrates the destructive role of RAS in increasing oxidative stress, inflammation and cell damage.
Neuro Vigor Therapeutics and our collaborators are pioneering new drugs to inhibit toxic molecules called reactive aldehyde species (RAS), which have been implicated in the pathogenesis of multiple diseases, neuropathic pain and trauma.
Video overview of our science & technology:
Neuro Vigor Therapeutics greatly benefits from ongoing relationships with impressive collaborators in science, research, drug development and business strategy. NVT welcomes inquiries regarding prospective collaboration and partnering opportunities.
Our current key collaborators include: